Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03680560
Title Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Unum Therapeutics Inc.

Advanced Solid Tumor


ACTR707 + Trastuzumab

ACTR087 + Trastuzumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale Smilow Cancer Hospital New Haven Connecticut 06511 United States Details
Miami University Cancer Center Miami Florida 33136 United States Details
The Ohio State University Columbus Ohio 43210 United States Details
Sarah Cannon Research Institute/Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
Baylor Scott & White Medical Center Dallas Texas 75201 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field